From Casetext: Smarter Legal Research

In re Darvocet, Darvon & Propoxyphene Prods. Liab. Litig.

UNITED STATES JUDICIAL PANEL on MULTIDISTRICT LITIGATION
Aug 31, 2011
2:11-cv-1498 KJM EFB (E.D. Cal. Aug. 31, 2011)

Opinion

2:11-cv-1498 KJM EFB

08-31-2011

In re: DARVOCET, DARVON AND PROPOXYPHENE PRODUCTS LIABILITY LITIGATION


(SEE ATTACHED SCHEDULE)


CONDITIONAL TRANSFER ORDER (CTO-1)

On August 16, 2011, the Panel transferred 17 civil action(s) to the United States District Court for the Eastern District of Kentucky for coordinated or consolidated pretrial proceedings pursuant to 28 U.S.C. §1407. See __F.Supp.2d__ (J.P.M.L. 2011). Since that time, no additional action(s) have been transferred to the Eastern District of Kentucky. With the consent of that court, all such actions have been assigned to the Honorable Danny C Reeves.

It appears that the action(s) on this conditional transfer order involve questions of fact that are common to the actions previously transferred to the Eastern District of Kentucky and assigned to Judge Reeves.

Pursuant to Rule 7.1 of the Rules of Procedure of the United States Judicial Panel on Multidistrict Litigation, the action(s) on the attached schedule are transferred under 28 U.S.C. §1407 to the Eastern District of Kentucky for the reasons stated in the order of August 16, 2011, and, with the consent of that court, assigned to the Honorable Danny C Reeves.

This order does not become effective until it is filed in the Office of the Clerk of the United States District Court for the Eastern District of Kentucky. The transmittal of this order to said Clerk shall be stayed 7 days from the entry thereof. If any party files a notice of opposition with the Clerk of the Panel within this 7-day period, the stay will be continued until further order of the Panel.

FOR THE PANEL:

Jeffery N. Luthi

Clerk of the Panel

SCHEDULE CTO-1 - TAG-ALONG ACTIONS

+------------------------------------------------------------------------+ ¦DIST ¦DIV. ¦C.A.NO. ¦CASE CAPTION ¦ +-----------------------+------------------------------------------------¦ ¦ALABAMA NORTHERN ¦ ¦ +-----------------------+------------------------------------------------¦ ¦ALN ¦5 ¦11-01662 ¦Kendrick v. Xanodyne Pharmaceuticals, Inc et al ¦ +-----------------------+------------------------------------------------¦ ¦CALIFORNIA CENTRAL ¦ ¦ +-----------------------+------------------------------------------------¦ ¦CAC ¦2 ¦11-06147 ¦Martha Teran v. Xanodyne Pharmaceuticals Inc ¦ +-----------------------+------------------------------------------------¦ ¦CALIFORNIA EASTERN ¦ ¦ +-----------------------+------------------------------------------------¦ ¦CAE ¦2 ¦11-01498 ¦Niebuhr, et al v. Xanodyne Pharmaceuticals, Inc.¦ +-----------------------+------------------------------------------------¦ ¦CALIFORNIA NORTHERN ¦ ¦ +-----------------------+------------------------------------------------¦ ¦CAN ¦3 ¦11-03974 ¦Weaver et al v. Eli Lilly &Company et al ¦ +-----------------------+------------------------------------------------¦ ¦FLORIDA SOUTHERN ¦ ¦ +-----------------------+------------------------------------------------¦ ¦FLS ¦9 ¦11-80188 ¦Germain et al v. Teva Pharmaceuticals USA, Inc. ¦ +-----------------------+------------------------------------------------¦ ¦GEORGIA NORTHERN ¦ ¦ +-----------------------+------------------------------------------------¦ ¦GAN ¦1 ¦11-01695 ¦Cross v. Xanodyne Pharmaceuticals, Inc. et al ¦ +-----------------------+------------------------------------------------¦ ¦INDIANA NORTHERN ¦ ¦ +-----------------------+------------------------------------------------¦ ¦INN ¦3 ¦11-00071 ¦Gianoli v. Xanodyne Pharmaceuticals Inc ¦ +-----------------------+------------------------------------------------¦ ¦INDIANA SOUTHERN ¦ ¦ +-----------------------+------------------------------------------------¦ ¦INS ¦4 ¦11-00079 ¦HALLAWAY et al v. ELI LILLY AND COMPANY et al ¦ +-----------------------+------------------------------------------------¦ ¦LOUISIANA EASTERN ¦ ¦ +-----------------------+------------------------------------------------¦ ¦LAE ¦2 ¦11-01000 ¦Rogers v. Xanodyne Pharmaceuticals, Inc. ¦ +------+------+---------+------------------------------------------------¦ ¦LAE ¦2 ¦11-01225 ¦Oniate et al v. Eli Lilly and Company et al ¦ +------------------------------------------------------------------------+

+----------------------------------------------------------------------+ ¦LOUISIANA WESTERN ¦ ¦ +--------------------+-------------------------------------------------¦ ¦LAW ¦5¦11-00444 ¦Juergens v. Xanodyne Pharmaceuticals Inc ¦ +-----+-+------------+-------------------------------------------------¦ ¦LAW ¦6¦11-01225 ¦Olivier v. Xanodyne Pharmaceuticals Inc ¦ +--------------------+-------------------------------------------------¦ ¦MINNESOTA ¦ ¦ +--------------------+-------------------------------------------------¦ ¦MN ¦0¦11-00893 ¦Lowe et al v. Xanodyne Pharmaceuticals Inc. ¦ +--------------------+-------------------------------------------------¦ ¦MISSISSIPPI SOUTHERN¦ ¦ +--------------------+-------------------------------------------------¦ ¦MSS ¦3¦11-00177 ¦Lynch v. Xanodyne Pharmaceuticals, Inc. et al ¦ +--------------------+-------------------------------------------------¦ ¦MISSOURI EASTERN ¦ ¦ +--------------------+-------------------------------------------------¦ ¦MOE ¦4¦11-01026 ¦Kinter v. MI Holdings, Inc. et al ¦ +--------------------+-------------------------------------------------¦ ¦NEW JERSEY ¦ ¦ +--------------------+-------------------------------------------------¦ ¦ ¦ ¦ ¦TEGTMEIER V. XANODYNE ¦ ¦NJ ¦2¦11-02668 ¦ ¦ ¦ ¦ ¦ ¦PHARMACEUTICALS, INC. ¦ +-----+-+------------+-------------------------------------------------¦ ¦NJ ¦2¦11-03913 ¦MEEKS v. XANODYNE PHARMACEUTICALS, INC. et al ¦ +--------------------+-------------------------------------------------¦ ¦OHIO NORTHERN ¦ ¦ +--------------------+-------------------------------------------------¦ ¦OHN ¦4¦10-02907 ¦Daugherty et al v. Xanodyne Pharmaceuticals, Inc.¦ +--------------------+-------------------------------------------------¦ ¦SOUTH CAROLINA ¦ ¦ +--------------------+-------------------------------------------------¦ ¦SC ¦6¦11-00835 ¦Coney v. Xanodyne Pharmaceuticals Inc et al ¦ +--------------------+-------------------------------------------------¦ ¦TENNESSEE WESTERN ¦ ¦ +--------------------+-------------------------------------------------¦ ¦TNW ¦2¦11-02197 ¦Knight et al v. TEVA Pharmaceuticals USA, In ¦ +--------------------+-------------------------------------------------¦ ¦TEXAS NORTHERN ¦ ¦ +--------------------+-------------------------------------------------¦ ¦TXN ¦3¦11-01011 ¦Cook v. Teva Pharmaceuticals USA Inc et al ¦ +--------------------+-------------------------------------------------¦ ¦TEXAS WESTERN ¦ ¦ +--------------------+-------------------------------------------------¦ ¦TXW ¦1¦11-00093 ¦Fuller et al v. Xanodyne Pharmaceuticals, Inc. ¦ +-----+-+------------+-------------------------------------------------¦ ¦TXW ¦1¦11-00500 ¦Simpson v. Qualitest Pharmaceuticals, Inc. et al ¦ +----------------------------------------------------------------------+


Summaries of

In re Darvocet, Darvon & Propoxyphene Prods. Liab. Litig.

UNITED STATES JUDICIAL PANEL on MULTIDISTRICT LITIGATION
Aug 31, 2011
2:11-cv-1498 KJM EFB (E.D. Cal. Aug. 31, 2011)
Case details for

In re Darvocet, Darvon & Propoxyphene Prods. Liab. Litig.

Case Details

Full title:In re: DARVOCET, DARVON AND PROPOXYPHENE PRODUCTS LIABILITY LITIGATION

Court:UNITED STATES JUDICIAL PANEL on MULTIDISTRICT LITIGATION

Date published: Aug 31, 2011

Citations

2:11-cv-1498 KJM EFB (E.D. Cal. Aug. 31, 2011)